Effects of Low-Level Laser Therapy on Mouth Opening and Surface Electromyography in Temporomandibular Disorders
Launched by CAIRO UNIVERSITY · Apr 1, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how low-level laser therapy (LLLT) can help women with temporomandibular joint dysfunction (TMD), a condition that can cause pain in the jaw and difficulty opening the mouth. The study will compare the effects of this laser treatment to soft occlusive splints, which are devices that help keep the jaw in a comfortable position. Researchers want to see how well LLLT can reduce pain, improve mouth opening, and enhance muscle activity in the jaw over a year.
To participate in this study, women should be under 30 years old and diagnosed with a specific type of TMD that affects one side of the jaw. They must have all of their permanent teeth and a normal bite. However, those with certain medical conditions, prior laser treatment, or who are currently taking specific medications will not be eligible. Participants can expect to receive either the laser treatment or the soft splints and will be monitored for changes in their symptoms over the course of the study. This trial is actively recruiting participants, and your involvement could contribute to understanding better ways to manage TMD.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Females less than 30 years of age, Diagnosed with unilateral myogenous TMD, Having complete permanent dentition Showing normal occlusion
- Exclusion Criteria:
- • Prior experience of Laser therapy, Systemic diseases (rheumatoid arthritis, ankylosing spondylitis, diabetes... etc. History of trauma in the TMJ or cervical regions; Neurological disorders, Muscular diseases; Cervical pain; Bruxism, Pregnancy; Currently on medication (analgesic, anti-inflammatory, muscle relaxants or anti- depressants) Current use of dental prosthetics; Previous orthodontal treatments; or Fixed restorations affecting occlusal surfaces.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Trial Officials
Tamer Shousha
Principal Investigator
Lecturer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials